Summary
Treatment with prescription omega-3 (P-OM3) fatty acids failed to reduce the risk of recurrent atrial fibrillation (AF) after 6 months compared with placebo in patients with paroxysmal AF, according to findings from a large randomized study.
- Cardiology Clinical Trials
- Arrhythmias
- © 2010 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.